You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Osiris Therapeutics Inc up (U.S.)$0.14

Osiris Therapeutics Inc closed up Tuesday by (U.S.)$0.14 or 0.81% to (U.S.)$17.52. Over the last five days, shares have gained 4.10% and 9.57% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

Open(U.S.) $17.50

Previous close(U.S.) $17.38

High(U.S.) $17.55

Low(U.S.) $17.17

Bid / Ask(U.S.) $14.50 / (U.S.) $17.68

YTD % change+9.57%

Volume177,318

Average volume (10-day)89,439

Average volume (1-month)95,128

Average volume (3-month)115,660

52-week range(U.S.) $11.80 to (U.S.) $17.69

Beta1.30

Trailing P/ENegative, not meaningful

P/E 1 year forward869.00×

Forward PEGNegative, not meaningful

Indicated annual dividend--

Dividend yield0.00%

Trailing EPS(U.S.) -$0.08

Updated March 3 4:00 PM -5GMT. Delayed by at least 15 minutes.

Key company metrics

Open(U.S.) $17.50

Previous close(U.S.) $17.38

High(U.S.) $17.55

Low(U.S.) $17.17

Bid / Ask(U.S.) $14.50 / (U.S.) $17.68

YTD % change+9.57%

Volume177,318

Average volume (10-day)89,439

Average volume (1-month)95,128

Average volume (3-month)115,660

52-week range(U.S.) $11.80 to (U.S.) $17.69

Beta1.30

Trailing P/ENegative, not meaningful

P/E 1 year forward869.00×

Forward PEGNegative, not meaningful

Indicated annual dividend--

Dividend yield0.00%

Trailing EPS(U.S.) -$0.08

Updated March 3 4:00 PM -5GMT. Delayed by at least 15 minutes.

About

Osiris Therapeutics, Inc., is a stem cell company. The Company is focused on developing and marketing products to treat medical conditions in the wound, orthopedic, and sports

Continue reading

medicine markets. As of December, 31, 2013, the Company markets and distributes Grafix and Ovation for acute and chronic wounds, Cartiform, a viable cartilage mess for cartilage repair and OvationOS, a viable bone matrix for bone growth. Grafix is a three-dimensional placental tissue matrix for use as a wound covering for application directly to acute and chronic wounds, including diabetic foot ulcers, venous leg ulcers, and burns. OvationOS, a viable bone matrix, is a product to be used for bone repair and regeneration. Cartiform is viable cartilage mesh designed for use in cartilage repair, such as marrow stimulation procedures.

Profit

Net Profit (TTM)

-5.23%

Osiris Therapeutics Inc has a net profit margin of -5.23%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit. Company Books

Restrictions

All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. Thomson Reuters is not liable for any errors or delays in Thomson Reuters content, or for any actions taken in reliance on such content. ‘Thomson Reuters’ and the Thomson Reuters logo are trademarks of Thomson Reuters and its affiliated companies.